- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07698418
Effect of Inspiratory Muscle Training on Knee Osteoarthritis Pain
Effect of Inspiratory Muscle Training on Pain in Patients With Knee Osteoarthritis: A Randomized Controlled Trial
Knee osteoarthritis (KOA) is a common joint disease that causes chronic pain and limits daily activities. Current treatments, such as painkillers or surgery, have limitations like side effects or high costs. This study will test whether a safe, non-drug intervention-inspiratory muscle training (breathing exercises against resistance)-can reduce knee pain in people with KOA. The training may work by lowering inflammation and improving the body's nervous system control of pain.
We plan to enroll 80 patients aged ≥55 years with confirmed KOA and frequent knee pain. Participants will be randomly assigned to either an 8-week inspiratory muscle training program (5 sessions per week, with gradually increasing resistance) or a sham (very low resistance) training program. Neither the patients nor the researchers assessing the outcomes will know who is in which group.
The main outcome is change in knee pain measured by a visual analog scale (VAS). Secondary outcomes include blood markers of inflammation (TNF-α, IL-6, IL1β), physical function, WOMAC score (a KOA-specific questionnaire), activity level, sleep quality, and quality of life. To explore underlying mechanisms, we will also measure heart rate variability (HRV) as an indicator of autonomic nervous system function, and brain functional connectivity in the prefrontal cortex using functional near-infrared spectroscopy (fNIRS). These mechanistic assessments will be performed at baseline and at the end of 8-week intervention. Additional follow-up assessments for clinical outcomes will be done at 3 and 6 months after the training ends. We will also record any side effects or adverse events.
This study will provide high-quality evidence on whether inspiratory muscle training is an effective and safe complementary treatment for knee pain in people with knee OA, and will offer new insights into the mechanisms underlying its analgesic effects.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- Aged 55 years or older.
- Knee osteoarthritis (Kellgren-Lawrence grade ≥ 2).
- Knee pain (Visual Analogue Scale, VAS ≥ 3) on the most days in the past month.
- Able to walk independently without assitive devices.
Exclusion Criteria:
- History of knee replacement surgery, meniscus surgery, or ligament surgery.
- Received corticosteroid injection within the previous three weeks.
- Diagnosed with rheumatoid arthritis.
- Unstable angina, recent myocardial infarction, uncontrolled cardiac arrhythmia, or severe heart failure.
- History of stroke.
- Currently receiving steroid therapy, hormonal therapy, or cancer chemotherapy.
- Pneumothorax, pulmonary bullae, lung surgery within the past 12 months, unstable asthma, or severe dyspnea at rest.
- Unable to understand the study procedures and potential risks.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Tredobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Inspiratory Muscle Training
5 sessions/week for 8 weeks.
Load starts at 50% MIP for 40 reps, increases to 80% MIP for 60 reps from week 5, then adjusted weekly to 80% of updated MIP.
Device: threshold inspiratory muscle trainer.
|
Participants will perform home-based inspiratory muscle training using a threshold-loading device (POWERbreathe Medic Plus).
Training is conducted 5 times per week for 8 weeks.
The initial inspiratory load is set at 50% of the individual's maximum inspiratory pressure (MIP), measured weekly at the study site.
The load is progressively increased to 80% MIP over the first 4 weeks and maintained at 80% MIP for the remaining 4 weeks.
Each session consists of 40-60 breaths.
Adherence is monitored via an electronic training log and weekly on-site visits.
This protocol is individualized, progressive, and home-based, distinguishing it from fixed-load or supervised-only breathing interventions.
Andre navne:
|
|
Sham-komparator: Sham Inspiratory Muscle Training
Participants perform sham inspiratory muscle training with the same frequency and duration as the experimental group, but the inspiratory load is fixed at 10% of maximal inspiratory pressure (MIP) and does not progress.
All other procedures (weekly MIP measurement for sham load adjustment) are identical to maintain blinding.
|
Participants will perform home-based inspiratory muscle training using a threshold-loading device (POWERbreathe Medic Plus).
Training is conducted 5 times per week for 8 weeks.
The initial inspiratory load is set at 50% of the individual's maximum inspiratory pressure (MIP), measured weekly at the study site.
The load is progressively increased to 80% MIP over the first 4 weeks and maintained at 80% MIP for the remaining 4 weeks.
Each session consists of 40-60 breaths.
Adherence is monitored via an electronic training log and weekly on-site visits.
This protocol is individualized, progressive, and home-based, distinguishing it from fixed-load or supervised-only breathing interventions.
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Visual analogue scale
Tidsramme: Baseline, week 8, 3-month after intervention, 6-month after intervention
|
Self-rated pain intensity of knee (0-10), "0" indicate no pain, "10" indicate worst pain.
|
Baseline, week 8, 3-month after intervention, 6-month after intervention
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Western Ontario and McMaster Universities Osteoarthritis Index
Tidsramme: Baseline, week 8, 3-month after intervention, 6-month after intervention
|
Patient-reported outcomes in symptoms and function, total scores range from 0-96, the higher scores indicating the worse symptom and function.
|
Baseline, week 8, 3-month after intervention, 6-month after intervention
|
|
Serum levels of inflammatory markers
Tidsramme: Baseline, up to week 8
|
Systemic inflammation
|
Baseline, up to week 8
|
|
Heart rate variability
Tidsramme: Baseline, up to week 8
|
Vagus nerve activity
|
Baseline, up to week 8
|
|
Prefrontal cortex activity
Tidsramme: Baseline, up to week 8
|
Functional near-infrared spectroscopy was used to assess prefrontal cortex activity
|
Baseline, up to week 8
|
|
40-meter walk test
Tidsramme: Baseline, up to week 8
|
Physical function
|
Baseline, up to week 8
|
|
30-sec chair stand test
Tidsramme: Baseline, up to week 8
|
Physical function
|
Baseline, up to week 8
|
|
Physical Activity Scales for the Elderly
Tidsramme: Baseline, week 8, 3-month after intervention, 6-month after intervention
|
Total scores range from 0-793, the higher scores indicating a higher level of physical activity.
|
Baseline, week 8, 3-month after intervention, 6-month after intervention
|
|
Pittsburgh Sleep Quality Index
Tidsramme: Baseline, week 8, 3-month after intervention, 6-month after intervention
|
Total scores range from 0-21, '0' indicating no difficulty and '21' indicating severe difficulties in all areas.
|
Baseline, week 8, 3-month after intervention, 6-month after intervention
|
|
12-Item Short Form Health Survey
Tidsramme: Baseline, week 8, 3-month after intervention, 6-month after intervention
|
Total scores range from 0-100, the higher scores indicating better physical and mental health functioning.
|
Baseline, week 8, 3-month after intervention, 6-month after intervention
|
|
Maximal inspiratory pressure
Tidsramme: Baseline, up to week 8
|
Inspiratory muscle strength
|
Baseline, up to week 8
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Adherence
Tidsramme: Up to week 8
|
Adherence was calculated from logbooks as completed versus prescribed sessions
|
Up to week 8
|
|
Adverse events
Tidsramme: Up to week 8
|
Adverse events were defined as any symptom or abnormal sign during training and graded by the Common Terminology Criteria for Adverse Events (CTCAE v6.0, 2025): Mild: resolved with rest, no medical intervention; Moderate: require minimal medical intervention (e.g., analgesics); Severe: requires medical attention or hospitalization (e.g., clinic visit)
|
Up to week 8
|
Samarbejdspartnere og efterforskere
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Smerte
- Neurologiske manifestationer
- Muskuloskeletale sygdomme
- Gigt
- Ledsygdomme
- Reumatiske sygdomme
- Slidgigt
- Patologiske tilstande, tegn og symptomer
- Tegn og symptomer
- Slidgigt, knæ
- Kronisk smerte
- Terapeutik
- Mind-body terapier
- Komplementære terapier
- Træningsbevægelsesteknikker
- Fysioterapimodaliteter
- Åndedrætsøvelser
Andre undersøgelses-id-numre
- ZHSC-1-(2026)014
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Knæ slidgigt
-
Smith & Nephew, Inc.Nor Consult, LLCAfsluttetJourney II XR Total Knee SystemForenede Stater
-
Smith & Nephew, Inc.AfsluttetSikkerhed og ydeevne af Journey II BCS Total Knee System Patient rapporterede resultatmål (JIIPROMS)Journey II BCS Total Knee SystemForenede Stater, Belgien, New Zealand
-
Smith & Nephew, Inc.Nor ConsultAfsluttetJourney II CR Total Knee SystemForenede Stater
-
Clinical Center of VojvodinaAktiv, ikke rekrutterendeOsteoarthritisSerbien
-
Gaziler Physical Medicine and Rehabilitation Education...RekrutteringOsteoarthritis | Knæ Arthritis, SlidgigtTyrkiet (Türkiye)
-
Indonesia UniversityAfsluttetKnæ slidgigt | OsteoarthritisIndonesien
-
Assiut UniversityIkke rekrutterer endnu
-
University of KarachiRekrutteringKnæ slidgigt | Knæsmerter Gigt | OsteoarthritisPakistan
-
Kirsehir Ahi Evran UniversitesiIkke rekrutterer endnu
-
Fundació EurecatHISPANAGAR SARekrutteringBetændelse | Bruskskade | Ledskade | OsteoarthritisSpanien
Kliniske forsøg med Inspiratory muscle training
-
University Health Network, TorontoAfsluttetHypermobil EDS (hEDS) | HypermobilitetssyndromCanada
-
Sahmyook UniversityAfsluttetSubakut slagtilfælde | BalanceunderskudSydkorea
-
Kirsehir Ahi Evran UniversitesiRekrutteringSund og raskTyrkiet (Türkiye)
-
Fundació Institut de Recerca de l'Hospital de la...AfsluttetSunde mennesker-programmerSpanien
-
Universidade Federal FluminenseAfsluttet
-
Clínica BasileaIkke rekrutterer endnuFysioterapimetoder, åndedrætsmuskler, maksimalt åndedrætstryk, vejrtrækningsøvelser
-
University Hospital, MontpellierAfsluttet
-
Istanbul UniversityKinesio Taping Association InternationalAfsluttetKronisk hjertesvigtKalkun
-
Gazi UniversityAfsluttetMotionstræningTyrkiet (Türkiye)